Completed Clinical Trials

Capecitabine in Treating Patients With Malignant Mesothelioma

By April 24, 2017No Comments


Malignant Mesothelioma

Estimated Enrollment: 27

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: CALGB-39807|U10CA031946|CLB-39807|CDR0000067422

Study First Received: January 21, 2000

Last Updated: July 12, 2016

Estimated Primary Completion Date: December 2003


Primary Outcome Measures:

Sponsors and Collaborators:

Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)

Website Link:

Leave a Reply

Call Now ButtonCall Now